secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0000724004-25-000012
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs 2Q26 revenue up 5%, net income down 27.8% on tariffs and China headwinds
--------------------------------------------------------------------------------

- Total revenues $60.7M, +5.0% YoY; core organic growth 3.7%.
- Net income $2.5M ($0.45 diluted EPS), down 27.8% from 2Q25.
- Non-GAAP AOI excluding unusual items $15.2M, +6.1%; margin 25.1% vs 24.8%.
- Clinical Genomics core organic -3.6%: China -58%; outside China +16.2%.
- Annualized cost reductions of $3.2M; net savings $2.3M after reinvestment. Tariffs 70 bps of revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000072400425000012/0000724004-25-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000072400425000012/mlab20251106_8k.htm
  HTML page:      https://secwatch.observer/filing/0000724004-25-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer